日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Prediction Analysis of Microarray of 50 genes (PAM50) classifier validated for predicting prostate cancer progression in active surveillance: Miami Active Surveillance Trial (MAST)

50基因微阵列预测分析(PAM50)分类器已验证可用于预测前列腺癌在主动监测中的进展:迈阿密主动监测试验(MAST)

Malpani, Ankur; Ryan, Jonathan T; Yu, Hui; Soodana-Prakash, Nachiketh; Khandekar, Archan; Ajami, Tarek; Williams, Adam; Szczotka, Zoe; Alshalalfa, Mohammed; Hao, Yangyang; Davicioni, Elai; Swain, Sanjaya; Kryvenko, Oleksandr N; Pra, Alan Dal; Stoyanova, Radka; Gaston, Sandra; Pollack, Alan; Mahal, Brandon A; Abramowitz, Matthew; Nahar, Bruno; Ritch, Chad R; Kava, Bruce; Gonzalgo, Mark L; Parekh, Dipen J; Punnen, Sanoj

Tertiary lymphoid structures in genitourinary cancers: a comprehensive review

泌尿生殖系统肿瘤的三级淋巴结构:一项综合综述

Abreu, Alvaro; Viera Plasencia, Alejandra; Iribarren, Mercy; Wegner, Carter; Nuraj, Joana; Davicioni, Elai; Bahmad, Hisham F; Shahait, Mohammed

Predicting dose response to prostate cancer radiotherapy: validation of a radiation signature in the randomized phase III NRG/RTOG 0126 and SAKK 09/10 trials

预测前列腺癌放射治疗的剂量反应:在随机 III 期 NRG/RTOG 0126 和 SAKK 09/10 试验中验证放射特征

Dal Pra, A; Ghadjar, P; Ryu, H M; Proudfoot, J A; Hayoz, S; Michalski, J M; Spratt, D E; Liu, Y; Schär, C; Berlin, A M; Zwahlen, D R; Simko, J P; Hölscher, T; Efstathiou, J A; Polat, B; Sandler, H M; Hildebrandt, G; Parliament, M B; Mueller, A-C; Dayes, I S; Plasswilm, L; Correa, R J M; Robertson, J M; Karrison, T G; Davicioni, E; Hall, W A; Feng, F Y; Pollack, A; Thalmann, G N; Nguyen, P L; Aebersold, D M; Tran, P T; Zhao, S G

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer

基因组规模的 CRISPR 筛选发现 PTGES3 是晚期前列腺癌中雄激素受体功能的直接调节因子

Haolong Li,James E Melnyk,Becky Xu Hua Fu,Raunak Shrestha,Meng Zhang,Martin Sjöström,Siyu Feng,Jasmine A Anderson,Wanting Han,Lisa N Chesner,Hyun Jin Shin,Tatyanah Farsh,Humberto J Suarez,Seema Nath,Jonathan Chou,Rajdeep Das,Emily A Egusa,Marsha Calvert,Audrey Kishishita,Abhilash Barpanda,Jun Zhu,Ashutosh Maheshwari,William S Chen,Mohammed Alshalalfa,Aidan Winters,Junjie T Hua,Tianyi Liu,Elai Davicioni,Arun P Wiita,Bradley A Stohr,Javed Siddiqui,Bo Huang,Eric J Small,Kevan M Shokat,Peter S Nelson,David A Quigley,Elizabeth V Wasmuth,Luke A Gilbert,Felix Y Feng

Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment.

空间多组学识别出侵袭性前列腺癌的特征,突显了肿瘤微环境中的促炎趋化因子活性。

Krossa Sebastian, Andersen Maria K, Sandholm Elise M, Wess Maximilian, Kiviaho Antti, Sharma Abhibhav, Hakkola Sini, Hao Yangyang, Alshalalfa Mohammed, Davicioni Elai, Viset Trond, Størkersen Øystein, Karnes R Jeffrey, Spratt Daniel E, Giskeødegård Guro F, Nykter Matti, Rye Morten B, Urbanucci Alfonso, Tessem May-Britt

Transcriptomic Profiling of the Tumor Immune Microenvironment Reveals Prognostic Markers in mCRPC Patients Treated with LuPSMA Therapy

肿瘤免疫微环境转录组分析揭示了接受 LuPSMA 疗法治疗的转移性去势抵抗性前列腺癌患者的预后标志物

Handke, Analena; Lopes, Leonor; Kesch, Claudia; Darr, Christopher; Davicioni, Elai; Shi, Kuangyu; Telli, Tugce; Fendler, Wolfgang P; Herrmann, Ken; Lückerath, Katharina; Hadaschik, Boris; Seifert, Robert

Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence

前列腺肿瘤在接受外照射放射治疗前的放射基因组学分析表明,TGF-β活性驱动肿瘤复发的转录组特征显著。

Anson T Ku ,Uma Shankavaram ,Shana Y Trostel ,Hong Zhang ,Sumeyra Kartal ,Houssein A Sater ,Stephanie A Harmon ,Nicole V Carrabba ,Yang Liu ,Hyunnam Ryu ,James A Proudfoot ,Boon Hao Hong ,Bradford J Wood ,Peter A Pinto ,Peter L Choyke ,Mack Roach ,Howard M Sandler ,Stephanie L Pugh ,Kenneth L Zeitzer ,Lucas C Mendez ,Nirav S Kapadia ,William A Hall ,Anand B Desai ,Radka S Stoyanova ,Alan Pollack ,Elai Davicioni ,Melvin L K Chua ,Baris Turkbey ,Adam G Sowalsky ,Deborah E Citrin

ATAD2 Drives Prostate Cancer Progression to Metastasis.

ATAD2 驱动前列腺癌进展至转移

Dutta Anindita, Rodriguez-Calero Antonio, Ronaldson-Bouchard Kacey, Offermann Anne, Rahman Daoud, Vhatkar Twinkle Bapuji, Hasson Dan, Alshalalfa Mohammed, Davicioni Elai, Karnes R Jeffrey, Rubin Mark A, Vunjak-Novakovic Gordana, Abate-Shen Cory, Arriaga Juan Martin

A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy

基于管腔非编码RNA的基因组分类器证实,接受根治性膀胱切除术治疗的临床局限性膀胱癌患者预后良好。

de Jong, Joep J; Proudfoot, James A; Daneshmand, Siamak; Svatek, Robert S; Narayan, Vikram; Gibb, Ewan A; Davicioni, Elai; Joshi, Shreyas; Dahmen, Aaron; Li, Roger; Inman, Brant A; Shah, Paras; Chaplin, Iftach; Wright, Jonathan; Lotan, Yair

Transcriptome profiling of prostatic tumours from ENACT trial patients with or without enzalutamide

对接受或未接受恩扎卢胺治疗的ENACT试验患者的前列腺肿瘤进行转录组分析

Handa, Nicole; Shore, Neal D; Cooperberg, Matthew R; Davicioni, Elai; Zhao, Xin; Elsouda, Dina; Liu, Yang; Proudfoot, James A; Kuperman, Gaston; Russell, David; Iwata, Kenneth K; Schaeffer, Edward M; Ross, Ashley